Factors influencing the uptake of atherogenic plasma proteins by artery walls

Biorheology

Volumn 40, Issue 1-3, 2002, Pages 13-22

  Born, Gustav V R ^a   Medina, R ^a   Shafi, Shahida ^a   Cardona Sanclemente, L E ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANGIOTENSIN; ANGIOTENSIN II ANTAGONIST; CAPTOPRIL; CATECHOLAMINE DERIVATIVE; DEOXYCORTICOSTERONE ACETATE; DERMATAN SULFATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN; HYPERTENSIVE AGENT; LOSARTAN; LOW DENSITY LIPOPROTEIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NORADRENALIN; PLASMA PROTEIN; RESERPINE; SODIUM CHLORIDE; THIAZIDE DIURETIC AGENT;

ACUTE HEART FAILURE; ARTERY ENDOTHELIUM; ARTERY WALL; ATHEROGENESIS; ATHEROSCLEROSIS; CELL DENSITY; CONFERENCE PAPER; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; FIBRINOGEN BLOOD LEVEL; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; NONHUMAN; PROTEIN TRANSPORT; RADIOACTIVITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK ASSESSMENT; RISK FACTOR; SPECIES DIFFERENCE; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE;

EID: 0036973326     PISSN: 0006355X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (46)

1. G.V.R. Born, Calcium and atherosclerosis, in: Calcium Antagonists and Atherosclerosis, G.V.R. Born, D.J. Triggle and P.A. Poole-Wilson, eds, Science Press, London, 1991, pp. 5-6.
2. L.D. Cardona-Sanclemente, J. Ferezou and C. Lutton, Cholesterol metabolism in the genetically hypercholesterolemic rat (RICO). II-Study of plasma lipoproteins and effect of dietary, cholesterol, Biochim. Biophys. Acta 960 (1988), 382-389.
3. L.E. Cardona-Sanclemente and G.V.R. Born, Adrenaline increases the uptake of low-density lipoproteins in carotid arteries of rabbits, Atherosclerosis 96 (1992), 215-218.
4. L.E. Cardona-Sanclemente and G.V.R. Born, Increased uptake of fibrinogen into arterial walls of unrestrained conscious rats caused by adrenaline and angiotensin II, Br. J. Pharmacol. (1992), 317.
5. L.E. Cardona-Sanclemente, R. Medina and G.V.R. Born, Effect of increasing concentrations of angiotensin II infused into unrestrained conscious rats on LDL and fibrinogen uptake by aorta, Br. J. Pharmacol. 111 (1994), 22P.
6. L.E. Cardona-Sanclemente, R. Medina and G.V.R. Born, Effect of increasing doses of angiotensin II infused into normal and hypertensive rats on low density lipoproteins and fibrinogen uptake by aortic walls, Proc. Natl. Acad. Sci. USA 91 (1994), 3285-3288.
7. L.E. Cardona-Sanclemente, R. Medina and G.V.R. Born, Effect of inhibition of nitric oxide synthesis on the uptake of LDL and fibrinogen by arterial walls and other organs of the rat, Br. J. Pharmacol. 114 (1985), 1490-1494.
8. L.E. Cardona-Sanclemente and G.V.R. Born, Increase by adrenaline or angiotensin II of the accumulation of low density lipoprotein and fibrinogen by aortic walls in unrestrained conscious rats, Br. J. Pharmacol. 117 (1996), 1089-1094.
9. P.E. Cryer, M.W. Haymond, J.V. Santiago and S.D. Shah, Norephinephine and ephinephrine release and adrenergic mediation of smoking-associated haemodynamic and metabolic events, New Engl. J. Med. 295 (1976), 327-339.
10. P.T. Davies and K.A. Barbee, Endothelial cell surface imaging: insights into hemodynamic force transduction, News Physiol. Sci. 9 (1994), 153-157.
11. X.J. Du, M.D. Esler and A.M. Dart, Sympatholytic action of intravenous amiodarone in the rat heart, Circulation 91 (1995), 462-470.
12. E. Ernst, W. Koenig, G.D.O. Lowe and T.W. Meade, in: Fibrinogen: A New Cardiovascular Risk Factor, Blackwell-MZD, Vienna, 1992.
13. C.M. Ferrario, A. Tramposh, Y. Kawano and K.B. Brosnihan, Sodium balance and the reflex regulation of baro-reflex function, Circulation 75 (Suppl. 1) (1987), 1141-1148.
14. J.L. Goldstein and M.S. Brown, The low density lipoprotein pathway and its relation with atherosclerosis, Ann. Rev. Biochem. 46 (1977), 897-930.
15. P. Görög and G.V.R. Born, Increased uptake of circulating low density lipoprotein and fibrinogen by arterial walls after removal of sialic acids from their endothelial surfaces, Br. J. Exp. Pathol. 63 (1982), 447-451.
16. Hardman et al., The Pharmacological Basis of Therapeutics, 9th edn, The MacGraw-Hill Companies, USA, 1996, p. 791.
17. R.J. Havel, H.A. Edner and J. Bragdon, The distribution and chemical composition of ultra-centrifugally separated lipoproteins in human serum, J. Clin. Invest. 34 (1955), 1345-1353.
18. J. Heinrich, L. Balleisen, H. Sculte, G. Assman and J. Van de Loo, Fibrinogen and factor VII in the prediction of coronary risk: results from the PROCAM study in healthy men, Arterioscl. Thromb. 14 (1994), 54-59.
19. A.T. Hirsch, Y.M. Pinto, H. Shunkert and V.J. Dzau, Potential role of the tissue renin-angiotensin system in the pathophysiology of congestive heart failure, Am. J. Cardiol. 66 (1990), 22D-23.
20. L.B. Jacques, L.M. Hiebert and S.M. Wice, Evidence from endothelium of gastric absorption of heparin and dextran sulphates 800, J. Lab. Clin. Med. 117 (1991), 122-130.
21. C. Ludlam, A. Arisawa and G.V.R. Born, Increased uptake of low density lipoprotein after heparinase perfusion of carotid arteries in anaesthetised rabbits, J. Physiol. (Lond.) 446 (1991), 220.
22. C. Ludlam and G.V.R. Born, Importance of the Electro-Negative Charge Properties of the Arterial Endothelium in Relation to Atherogenesis: Effect of Dermatan Sulphate on the Intravascular Clearance of Low Density Lipoproteins in Rabbits and Mice in Vivo, W. Siengenthaler and R. Haas, eds, Vol. 6, Publikationen der Jung-Stiftung für Wissenschatt und Forschung, Hamburg, 1994, pp. 233-241.
23. R.W. Mahley, T.L. Innerarity, K.L. Weisgraber and S.Y. Oh, Altered metabolism (in vivo and in vitro) of plasma lipoproteins after selective chemical modification of lysine residues of the apoproteins, J. Clin. Invest. 64 (1979), 743-750.
24. T.W. Meade, S. Mellows, M. Brozovic, I.G. Miller, R.R. Chakrabarti, W.R.S. North, A.P. Haines, Y. Stirling, J.D. Imeson and S.G. Thomson, Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study, Lancet II (1986), 533-537.
25. R. Medina, L.E. Cardona-Sanclemente and G.V.R. Born, Effect of captopril and of losartan on blood pressure and accumulation of LDL and fibrinogen by aortic wall and other tissues in normotensive and hypertensive rats, J. Cardiovasc. Pharmacol. 29 (1997), 125-129.
26. R. Medina, L.E. Cardona-Sanclemente, G.V.R. Born and M.J. Brown, Effect of deoxicorcosterone acetate on blood preserve in relation to accumulation of low density lipoprotein and fibrinogen by aorta and other tissue of normotensive Wistar rats, J. Hypertens. (1997) (in press).
27. C.C. Michel, Transport of the macromolecules through microvascular walls, Cardiovasc. Res. 32 (1996), 644-653.
28. H. Moffitt, G. Clough and C.C. Michel, Effects of intralumenal pressures on the labelling of endothelial cell vesicles with native ferritin, Int. J. Microcirc. Clin. Exp. 11 (1992), 90.
29. S. Moncada, The L-arginine: nitric oxide pathway, Acta Physiol. Scand. (1992), 201-227.
30. R.C. Pittmann, T.E. Carew, C.K. Glass, S.R. Green, C.A. Taylor and A.D. Attie, A radioiodinated, intracellularly trapped ligand for determining the sites of plasma protein degradation in vivo, Biochem. J. 212 (1983), 791-800.
31. D.D. Rees, R.M.T. Palmer, R. Schulz, H.F. Hodson and S. Moncada, Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo, Br. J. Pharmacol. 101 (1990), 746-752.
32. P.H. Rolland, P.K. Carpiot, A. Friggi, P. Piquet, A. Barlatier, E. Scalbert, H. Bodard, P. Tranier, C. Mercier and R. Luccioni, Effects of angiotensin-converting enzyme inhibition with perindopril on hemodynamics, arterial structure, and wall rheology in the hindquarters of atherosclerotic mini-pigs, Am. J. Cardiol. 71 (1993), 223-227.
33. J. Schenck and J.H. McNeil, The pathogenesis of DOCA-salt hypertension, J. Pharmacol. Toxicol. Methods 27 (1992), 161-170.
34. J.E. Schnitzer and P. Oh, Albondin-mediated capillary permeability to albumin, J. Biol. Chem. 269 (1994), 6072-6082.
35. S. Shafi, N.J. Cusack and G.V.R. Born, Increased uptake of methylated low density lipoprotein induced by noradrenaline in carotid arteries of anaesthetised rabbits, Proc. R. Soc. Lond. B 235 (1989), 289-298.
36. N. Simionescu, E. Vasile, F. Lupu, G. Popescu and M. Simionescu, Prelesional events in atherogenesis, Am. J. Pathol. 123 (1986), 109-125.
37. N. Simionescu and M. Simionescu, Endothelial injury and atherosclerosis, in: Endothelial Cell Biology in Health and Disease, Plenum Press, New York, 1988, pp. 385-429.
38. E. Smith and L. Crosbie, Fibrinogen and fibrin in atherogenesis, in: Fibrinogen: A New Cardiovascular Risk Factor, E. Ernst, W. Koenig, G.D.O. Lowe, T.W. Meade, eds, Blackwell-MZD, Vienna, 1992, pp. 4-10.
39. O. Stein and Y. Stein, Lipid synthesis and degradation and lipoprotein transport in mammalian aorta, in: Atherogenesis: Initiating Factors. Ciba Found Sym. 1973, Vol. 12, 1973, pp. 165-184.
40. K. Sudhir, J.S. MacGregor, M. Gupta, S.D. Barbant, R. Redbreg, P.G. Yock and K. Chatterjee, Effect of selective an-giotensin II receptor antagonism and angiotensin converting enzyme inhibition on the coronary vasculature in vivo, Circulation 87 (1993), 91-938.
41. V.W.M. Van Hinsbergh, L. Havekes, J.J. Emets, E. Van Corven and M. Scheffer, Low density lipoprotein metabolism by endothelial cells from human umbilical cord arteries and veins, Arteriosclerosis 3 (1983), 547-559.
42. E.Vasile, M. Simionescu and N. Simionescu, Visualization of the binding, endocytosis, and transcytosis of low density lipoproteins in the arterial endothelium in situ, J. Cell. Biol. 96 (1983), 1677-1689.
43. Veteran Administration Medical Centre, Low doses v. standard doses of reserpine: a randomised doubleblind multiclinic trial in patients taking chlorthalidone, JAMA 248(19) (1982), 674-686.
44. K.H. Weisgraber, T.L. Innearity and R.W. Mahley, Role of the lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts, J. Biol. Chem. 253 (1978), 9053-9062.
45. O. Wiklund, T.E. Carew and D. Steinberg, The role of low density lipoprotein receptor in the penetration of low density lipoprotein into rabbit aortic wall, Arteriosclerosis 5 (1985), 135-141.
46. L. Wilhelmsen, K. Svardsudd, K. Kordan-Bengtsen, B. Larsson, L. Welin, G. Tibblin, Fibrinogen as a risk factor for stroke and myocardial infarction, New Engl. J. Med. (1984), 501-505.